Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP
Clinical trial NCT04054882 · COMPLETED
Trial details
- NCT number
- NCT04054882
- Sponsor
- China National Biotec Group Company Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-16
- Primary completion
- 2020-03-30
- Enrollment
- 702
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.